Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Emergence of Resistance in Intestinal Microflora During Carbapenem Treatments

Trial Profile

Emergence of Resistance in Intestinal Microflora During Carbapenem Treatments

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jul 2017

At a glance

  • Drugs Ertapenem (Primary) ; Imipenem (Primary)
  • Indications Gram-negative infections
  • Focus Therapeutic Use
  • Acronyms ERIC
  • Most Recent Events

    • 13 Jun 2014 Status changed from active, no longer recruiting to completed as per ClinicalTrails.gov record.
    • 08 Jan 2014 Status changed from recruiting to active, no longer recruiting as per ClinicalTrails.gov
    • 26 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top